Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Survey of Ophthalmology

Volumn 54, Issue 6, 2009, Pages 686-696

  Shay, Elizabeth ^a   Kheirkhah, Ahmad ^b   Liang, Lingyi ^b   Sheha, Hossam ^b   Gregory, Darren G ^c   Tseng, Scheffer C G ^a,b  

^a TISSUETECH INC   (United States)

^b OCULAR SURFACE CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

amniotic membrane transplantation; blindness; cicatricial pathology; corneal complication; scarring; Stevens Johnson syndrome; toxic epidermal necrolysis

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN;

ACUTE DISEASE; AMNION TRANSPLANTATION; ARTICLE; BLINDNESS; CHRONIC DISEASE; CORNEA DISEASE; CRYOPRESERVATION; DISEASE SEVERITY; DRUG EFFICACY; EYE DISEASE; EYE SURGERY; HUMAN; LITERATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; SCAR FORMATION; STEVENS JOHNSON SYNDROME; SURGICAL TECHNIQUE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; VISUAL ACUITY;

ACUTE DISEASE; AMNION; CHILD; CHILD, PRESCHOOL; CONJUNCTIVAL DISEASES; CORNEAL DISEASES; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; STEVENS-JOHNSON SYNDROME; TISSUE PRESERVATION; WOUND HEALING;

EID: 70349772162     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2009.03.004     Document Type: Article

References (90)

1. Adds P.J., Hunt C.J., and Dart J.K. Amniotic membrane grafts, "fresh" or frozen? A clinical and in vitro comparison. Br J Ophthalmol 85 (2001) 905-907
2. Aihara Y., Ito R., Ito S., et al. Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone. Pediatr Int 49 5 (2007 Oct) 659-662
3. Arevalo J.M., Lorente J.A., Gonzalez-Herrada C., and Jimenez-Reyes J. Treatment of toxic epidermal necrolysis with cyclosporin A. J Trauma 48 3 (2000) 473-478
4. Arora R., Mehta D., and Jain V. Amniotic membrane transplantation in acute chemical burns. Eye 19 3 (2005 Mar) 273-278
5. Arstikaitis M.J. Ocular aftermath of Stevens-Johnson syndrome. Arch Ophthalmol 90 5 (1973 Nov) 376-379
6. Ashby D.W., and Lazar T. Erythema multiforme exudativum major (Stevens-Johnson syndrome). Lancet 1 20 (1951) 1091-1095
7. Belfort Jr. R., de S.M., Whitcup S.M., et al. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS. Cornea 10 6 (1991) 536-538
8. Bottinger L.E., Strandberg I., and Westerholm B. Drug-induced febrile mucocutaneous syndrome: with a review of literature. Acta Med Scand 198 (1975) 229-233
9. Bouchard C.S., and John T. Amniotic membrane transplantation in the management of severe ocular surface disease: indications and outcomes. Ocular Surface 2 3 (2004) 201-211
10. Brilakis H.S., Palmon F.E., Webster G.F., and Holland E.J. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. In: Krachmer J.H., Mannis M.J., and Holland E.J. (Eds). Cornea. ed. 2, (2005), Mosby, Philadelphia 691-702
11. Burman S., Tejwani S., Vemuganti G.K., et al. Ophthalmic applications of preserved human amniotic membrane: a review of current indications. Cell Tissue Bank 5 3 (2004) 161-175
12. Chan H.L., Stern R.S., Arndt K.A., et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 126 1 (1990) 43-47
13. Chang Y.S., Huang F.C., Tseng S.H., et al. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26 2 (2007) 123-129
14. Chave T.A., Mortimer N.J., Sladden M.J., et al. Toxic epidermal necrolysis: current evidence, practical management and future directions. Br J Dermatol 153 2 (2005) 241-253
15. Chen J., Zhou S., Huang T., et al. [A clinical study on fresh amniotic membrane transplantation for treatment of severe ocular surface disorders at acute inflammatory and cicatricial stage]. Zhonghua Yan Ke Za Zhi 36 1 (2000) 13-17
16. Di Pascuale M.A., Espana E.M., Liu D.T., et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112 5 (2005) 904-912
17. Dohlman C.H., and Doughman D.J. The Stevens-Johnson Syndrome. Trans New Orleans Acad Ophthalmol 24 (1972) 236-252
18. Dua H.S., and Azuara-Blanco A. Allo-limbal transplantation in patients with limbal stem cell deficiency. Br J Ophthalmol 83 (1999) 414-419
19. Dua H.S., Gomes J.A., King A.J., and Maharajan V.S. The amniotic membrane in ophthalmology. Surv Ophthalmol 49 1 (2004 Jan) 51-77
20. Dua H.S., Jagjit S.S., Azuara-Blanco A., and Gupta P. Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol 48 (2000) 83-92
21. Espana E.M., Di Pascuale M., Grueterich M., et al. Keratolimbal allograft in corneal reconstruction. Eye 18 4 (2004) 406-417
22. French L.E. Toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Allergol Int 55 1 (2006) 9-16
23. Grueterich M., Espana E.M., and Tseng S.C.G. Ex vivo expansion of limbal epithelial stem cells: amniotic membrane serving as a stem cell niche. Surv Ophthalmol 48 (2003) 631-646
24. Hazin R., Ibrahimi O.A., Hazin M.I., and Kimyai-Asadi A. Stevens-Johnson syndrome: pathogenesis, diagnosis, and management. Ann Med 40 2 (2008) 129-138
25. Howard G.M. The Stevens-Johnson syndrome. Ocular prognosis and treatment. Am J Ophthalmol 55 (1963) 893-900
26. John T., Foulks G.N., John M.E., et al. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109 2 (2002) 351-360
27. Khalili B., and Bahna S.L. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann Allergy Asthma Immunol 97 3 (2006) 272-280
28. Kheirkhah A., Johnson D.A., Paranjpe D.R., et al. Temporary sutureless amniotic membrane patch for acute alkaline burns. Arch Ophthalmol 126 8 (2008) 1059-1066
29. Kim J.S., Kim J.C., Na B.K., et al. Amniotic membrane patching promotes healing and inhibits protease activity on wound healing following acute corneal alkali burns. Exp Eye Res 70 (2000) 329-337
30. Kobayashi A., Shirao Y., Yoshita T., et al. Temporary amniotic membrane patching for acute chemical burns. Eye 17 (2003) 149-158
31. Kobayashi A., Yoshita T., Sugiyama K., et al. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology 113 1 (2006) 126-132
32. Koizumi N., Inatomi T., Suzuki T., et al. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 108 (2001) 1569-1574
33. Lavker R.M., Tseng S.C., and Sun T.T. Corneal epithelial stem cells at the limbus: looking at some old problems from a new angle. Exp Eye Res 78 3 (2004) 433-446
34. Lee N.J., Wang S.J., Durairaj K.K., et al. Increased expression of transforming growth factor-beta1, acidic fibroblast growth factor, and basic fibroblast growth factor in fetal versus adult fibroblast cell lines. Laryngoscope 110 4 (2000) 616-619
35. Lee S.H., and Tseng S.C.G. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123 (1997) 303-312
36. Lerner L.H., Qureshi A.A., Reddy B.V., and Lerner E.A. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome. J Invest Dermatol 114 1 (2000) 196-199
37. Letko E., Papaliodis D.N., Papaliodis G.N., et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 94 4 (2005) 419-436
38. Liu C., Paul B., Tandon R., et al. The osteo-odonto-keratoprosthesis (OOKP). Semin Ophthalmol 20 2 (2005) 113-128
39. Luo H.Y., Peng S.M., and Wang Y.J. [Fresh amniotic membrane transplantation for ocular surface diseases]. Di Yi Jun Yi Da Xue Xue Bao 23 5 (2003) 488-489
40. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68 11 (1956) 355-361
41. Meller D., Pires R.T., Mack R.J., et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107 5 (2000) 980-989
42. Mockenhaupt M., and Schopf E. Epidemiology of drug-induced severe skin reactions. Semin Cutan Med Surg 15 4 (1996) 236-243
43. Mondino B.J. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 97 7 (1990) 939-952
44. Muqit M.M., Ellingham R.B., and Daniel C. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome. Br J Ophthalmol 91 11 (2007) 1536
45. Naldi L., Locati F., Marchesi L., and Cainelli T. Incidence of toxic epidermal necrolysis in Italy. Arch Dermatol 126 8 (1990) 1103-1104
46. Nassif A., Bensussan A., Dorothee G., et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 118 4 (2002) 728-733
47. Ostler H.B., Conant M.A., and Groundwater J. Lyell's disease, the Stevens-Johnson syndrome, and exfoliative dermatitis. Trans Am Acad Ophthalmol. Otolaryngol 74 6 (1970) 1254-1265
48. Paquet P., Nikkels A., Arrese J.E., et al. Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 130 5 (1994) 605-608
49. Paquet P., Pierard G.E., and Quatresooz P. Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome). Int Arch Allergy Immunol 136 3 (2005) 205-216
50. Patz A. Ocular involvement in erythema multiforme. Arch Ophthalmol 43 2 (1950) 244-256
51. Paul C., Wolkenstein P., Adle H., et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134 4 (1996) 710-714
52. Posadas S.J., Padial A., Torres M.J., et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 109 1 (2002) 155-161
53. Power W.J., Ghoraishi M., Merayo-Lloves J., et al. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 102 (1995) 1669-1676
54. Prabhasawat P., Kosrirukvongs P., Booranapong W., and Vajaradul Y. Amniotic membrane transplantation for ocular surface reconstruction. J Med Assoc Thai 84 5 (2001) 705-718
55. Ralph R.A. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest Ophthalmol 14 4 (1975) 299-302
56. Raviglione M.C., Pablos-Mendez A., and Battan R. Clinical features and management of severe dermatological reactions to drugs. Drug Saf 5 1 (1990) 39-64
57. Roujeau J.C. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 102 6 (1994) 28S-30S
58. Sangwan V.S., Burman S., Tejwani S., et al. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol 55 4 (2007) 251-260
59. Sayegh R.R., Ang L.P., Foster C.S., and Dohlman C.H. The Boston keratoprosthesis in Stevens-Johnson syndrome. Am J Ophthalmol 145 3 (2008) 438-444
60. Scheinfeld N. A review of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops: possible uses and known side effects in cutaneous medicine. J Drugs Dermatol 6 3 (2007) 352-355
61. Schneck J., Fagot J.P., Sekula P., et al. Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study. J Am Acad Dermatol 58 1 (2008) 33-40
62. Schopf E., Stuhmer A., Rzany B., et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 127 6 (1991) 839-842
63. Shimmura S., Shimazaki J., Ohashi Y., and Tsubota K. Anti-inflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20 4 (2001) 408-413
64. Sippel K.C., Ma J.J.K., and Foster C.S. Amniotic membrane surgery. Curr Opin Ophthalmol 12 (2001) 269-281
65. Solomon A., Ellies P., Anderson D.F., et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109 6 (2002) 1159-1166
66. Solomon A., Espana E.M., and Tseng S.C.G. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110 (2003) 93-100
67. Solomon A., Meller D., Prabhasawat P., et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 109 4 (2002) 694-703
68. Sridhar M.S., Bansal A.K., Sangwan V.S., and Rao G.N. Amniotic membrane transplantation in acute chemical and thermal injury. Am J Ophthalmol 130 (2000) 134-137
69. Stevens A.M., and Johnson F.C. A new eruptive fever associated with stomatitis and opthalmitis. Report of two cases in children. Am J Dis Child 24 6 (1922) 526-533
70. Tandon A., Cackett P., Mulvihill A., and Fleck B. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis. J AAPOS 11 6 (2007) 612-613
71. Tejwani S., Kolari R.S., Sangwan V.S., and Rao G.N. Role of amniotic membrane graft for ocular chemical and thermal injuries. Cornea 26 1 (2007) 21-26
72. Tonnesen M.G., and Soter N.A. Erythema multiforme. J Am Acad Dermatol 1 4 (1979) 357-364
73. Tseng S.C. Amniotic membrane transplantation for ocular surface reconstruction. Biosci Rep 21 4 (2001) 481-489
74. Tseng S.C.G. Regulation and clinical implications of corneal epithelial stem cells. Mol Biol Rep 23 (1996) 47-58
75. Tseng S.C.G., Chen J.J.Y., Huang A.J.W., et al. Classification of conjunctival surgeries for corneal disease based on stem cell concept. Clin North Am Ophthalmol 3 (1990) 595-610
76. Tseng S.C.G., Di Pascuale M.A., Liu D.Z., et al. Intraoperative mitomycin C and amniotic membrane transplantation for fornix reconstruction in severe cicatricial ocular surface diseases. Ophthalmology 112 (2005) 896-903
77. Tseng S.C.G., Espana E.M., Kawakita T., et al. How does amniotic membrane work?. Ocular Surface 2 3 (2004) 177-187
78. Tseng S.C.G., Li D.Q., and Ma X. Suppression of transforming growth factor isoforms, TGF-b receptor II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 179 (1999) 325-335
79. Ueta M., Kweon M.N., Sano Y., et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol 129 3 (2002) 464-470
80. Viard I., Wehrli P., Bullani R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 5388 (1998) 490-493
81. Viard-Leveugle I., Bullani R.R., Meda P., et al. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. J Biol Chem 278 18 (2003) 16183-16188
82. Westly E.D., and Wechsler H.L. Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator. Arch Dermatol 120 6 (1984) 721-726
83. Wright P., and Collin J.R. The ocular complications of erythema multiforme (Stevens Johnson syndrome) and their management. Trans Ophthalmol Soc UK 103 Pt 3 (1983) 338-341
84. Yaghouti F., Nouri M., Abad J.C., et al. Keratoprosthesis: preoperative prognostic categories. Cornea 20 1 (2001) 19-23
85. Yang R., Wang F., and Sun N. [Application of fresh amniotic membrane transplantation in treatment of stenosis of conjunctival sac]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 18 4 (2004) 277-280
86. Yetiv J.Z., Bianchine J.R., and Owen Jr. J.A. Etiologic factors of the Stevens-Johnson syndrome. South Med J 73 5 (1980) 599-602
87. Zhao F., Xu W., and Guan J. [Clinical observation on fresh amniotic membrane transplantation for treatment of recurrent pterygium]. Yan Ke Xue Bao 18 4 (2002) 220-222
88. Zhou S., Chen J., Fung B., and Chen L. Fresh amniotic membrane transplantation combined lamellar keratoplasty for patients with recurrent Mooren's ulcer. Yan Ke Xue Bao 19 1 (2003) 1-5
89. Zhou S., Chen J., Xu L., et al. Fresh amniotic membrane transplantation for conjunctival surface reconstruction. Yan Ke Xue Bao 15 3 (1999) 169-173
90. Zhou S., Yuan J., Chen L., and Chen J. [Fresh versus preserved amniotic membrane transplantation for conjunctival surface reconstruction]. Yan Ke Xue Bao 24 1 (2008) 39-43